{"entity":{"type":"insider","cik":"0001579872","url":"/insider/0001579872","json_url":"/insider/0001579872.json","name":"Patel Mahesh V.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":22,"first":"2014-11-13","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Patel Mahesh V.","source":"filing","n_filings":22,"first_seen":"2014-11-13","last_seen":"2026-04-06"}],"transactions":[{"id":5740456,"accession":"0001493152-26-015357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-015357","line_url":"/filing/0001493152-26-015357#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":50750.0,"total_display":"50,750.00","shares_owned_after":160679.0,"shares_owned_after_display":"160,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-06","scope":"insider"},{"id":6148400,"accession":"0001493152-26-014959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-014959","line_url":"/filing/0001493152-26-014959#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":50500.0,"total_display":"50,500.00","shares_owned_after":135679.0,"shares_owned_after_display":"135,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider"},{"id":8264988,"accession":"0001493152-23-019050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-019050","line_url":"/filing/0001493152-23-019050#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8706.0,"shares_display":"8,706","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":43791.18,"total_display":"43,791.18","shares_owned_after":107418.0,"shares_owned_after_display":"107,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-25","filed_date":"2023-05-25","scope":"insider"},{"id":8496678,"accession":"0001493152-23-008943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-008943","line_url":"/filing/0001493152-23-008943#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","shares_owned_after":1678090.0,"shares_owned_after_display":"1,678,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-24","scope":"insider"},{"id":7903224,"accession":"0001493152-23-008087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-008087","line_url":"/filing/0001493152-23-008087#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":16500.0,"total_display":"16,500.00","shares_owned_after":1528090.0,"shares_owned_after_display":"1,528,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-17","scope":"insider"},{"id":6936443,"accession":"0001493152-22-031971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-031971","line_url":"/filing/0001493152-22-031971#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":29250.0,"total_display":"29,250.00","shares_owned_after":1478090.0,"shares_owned_after_display":"1,478,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-14","scope":"insider"},{"id":6302069,"accession":"0001493152-22-026945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-026945","line_url":"/filing/0001493152-22-026945#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":41000.0,"total_display":"41,000.00","shares_owned_after":1403090.0,"shares_owned_after_display":"1,403,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-27","scope":"insider"},{"id":6181521,"accession":"0001493152-22-014014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-014014","line_url":"/filing/0001493152-22-014014#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.7699,"price_display":"0.77","price_state":"stated","total_value":38495.0,"total_display":"38,495.00","shares_owned_after":1303090.0,"shares_owned_after_display":"1,303,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":4558780,"accession":"0001493152-21-029268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-029268","line_url":"/filing/0001493152-21-029268#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":27250.0,"total_display":"27,250.00","shares_owned_after":1253090.0,"shares_owned_after_display":"1,253,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":2933134,"accession":"0001638599-20-000977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-20-000977","line_url":"/filing/0001638599-20-000977#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","shares_owned_after":1228090.0,"shares_owned_after_display":"1,228,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":3315880,"accession":"0001638599-20-000949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-20-000949","line_url":"/filing/0001638599-20-000949#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43500.0,"shares_display":"43,500","price_per_share":1.5663,"price_display":"1.57","price_state":"stated","total_value":68134.05,"total_display":"68,134.05","shares_owned_after":1075112.0,"shares_owned_after_display":"1,075,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider"},{"id":2548514,"accession":"0001638599-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001638599-20-000002","line_url":"/filing/0001638599-20-000002#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.3835,"price_display":"0.38","price_state":"stated","total_value":15340.0,"total_display":"15,340.00","shares_owned_after":973612.0,"shares_owned_after_display":"973,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-31","filed_date":"2020-01-02","scope":"insider"},{"id":8531450,"accession":"0001638599-19-001020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001638599-19-001020","line_url":"/filing/0001638599-19-001020#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.399,"price_display":"0.40","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","shares_owned_after":933612.0,"shares_owned_after_display":"933,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-10","scope":"insider"},{"id":8595088,"accession":"0001638599-19-001010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-19-001010","line_url":"/filing/0001638599-19-001010#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43500.0,"shares_display":"43,500","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":17835.0,"total_display":"17,835.00","shares_owned_after":908612.0,"shares_owned_after_display":"908,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-06","scope":"insider"},{"id":8466180,"accession":"0001638599-19-000975","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001638599-19-000975","line_url":"/filing/0001638599-19-000975#line-4","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21928.0,"shares_display":"21,928","price_per_share":0.428,"price_display":"0.43","price_state":"stated","total_value":9385.184,"total_display":"9,385.18","shares_owned_after":807112.0,"shares_owned_after_display":"807,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-26","scope":"insider"},{"id":8466177,"accession":"0001638599-19-000975","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001638599-19-000975","line_url":"/filing/0001638599-19-000975#line-3","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1272.0,"shares_display":"1,272","price_per_share":0.4265,"price_display":"0.43","price_state":"stated","total_value":542.508,"total_display":"542.51","shares_owned_after":783384.0,"shares_owned_after_display":"783,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-26","scope":"insider"},{"id":8466171,"accession":"0001638599-19-000975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-19-000975","line_url":"/filing/0001638599-19-000975#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":0.427,"price_display":"0.43","price_state":"stated","total_value":469.7,"total_display":"469.70","shares_owned_after":785184.0,"shares_owned_after_display":"785,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-26","scope":"insider"},{"id":8466167,"accession":"0001638599-19-000975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001638599-19-000975","line_url":"/filing/0001638599-19-000975#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":0.4266,"price_display":"0.43","price_state":"stated","total_value":298.62,"total_display":"298.62","shares_owned_after":784084.0,"shares_owned_after_display":"784,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-26","scope":"insider"},{"id":7959764,"accession":"0001638599-19-000966","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001638599-19-000966","line_url":"/filing/0001638599-19-000966#line-3","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40259.0,"shares_display":"40,259","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":16103.6,"total_display":"16,103.60","shares_owned_after":777302.0,"shares_owned_after_display":"777,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":7959761,"accession":"0001638599-19-000966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-19-000966","line_url":"/filing/0001638599-19-000966#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4931.0,"shares_display":"4,931","price_per_share":0.3999,"price_display":"0.40","price_state":"stated","total_value":1971.9069,"total_display":"1,971.91","shares_owned_after":737043.0,"shares_owned_after_display":"737,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":7959758,"accession":"0001638599-19-000966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001638599-19-000966","line_url":"/filing/0001638599-19-000966#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4810.0,"shares_display":"4,810","price_per_share":0.4198,"price_display":"0.42","price_state":"stated","total_value":2019.238,"total_display":"2,019.24","shares_owned_after":782112.0,"shares_owned_after_display":"782,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6763421,"accession":"0001638599-18-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001638599-18-000029","line_url":"/filing/0001638599-18-000029#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":3.4778,"price_display":"3.48","price_state":"stated","total_value":20866.8,"total_display":"20,866.80","shares_owned_after":722112.0,"shares_owned_after_display":"722,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-02","scope":"insider"},{"id":8673634,"accession":"0001144204-15-057845","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-15-057845","line_url":"/filing/0001144204-15-057845#line-3","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","shares_owned_after":885632.0,"shares_owned_after_display":"885,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-30","filed_date":"2015-10-02","scope":"insider"},{"id":8673631,"accession":"0001144204-15-057845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-057845","line_url":"/filing/0001144204-15-057845#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":11.676,"price_display":"11.68","price_state":"stated","total_value":15178.8,"total_display":"15,178.80","shares_owned_after":887632.0,"shares_owned_after_display":"887,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-30","filed_date":"2015-10-02","scope":"insider"},{"id":8673629,"accession":"0001144204-15-057845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-057845","line_url":"/filing/0001144204-15-057845#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":11.6799,"price_display":"11.68","price_state":"stated","total_value":8175.93,"total_display":"8,175.93","shares_owned_after":886332.0,"shares_owned_after_display":"886,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-30","filed_date":"2015-10-02","scope":"insider"},{"id":6970643,"accession":"0001144204-14-070854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-070854","line_url":"/filing/0001144204-14-070854#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":10200.0,"total_display":"10,200.00","shares_owned_after":885632.0,"shares_owned_after_display":"885,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6970639,"accession":"0001144204-14-070597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-070597","line_url":"/filing/0001144204-14-070597#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":10900.0,"total_display":"10,900.00","shares_owned_after":883632.0,"shares_owned_after_display":"883,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-24","scope":"insider"},{"id":6200463,"accession":"0001144204-14-068371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-068371","line_url":"/filing/0001144204-14-068371#line-2","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":9614.0,"total_display":"9,614.00","shares_owned_after":881532.0,"shares_owned_after_display":"881,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-14","scope":"insider"},{"id":6200457,"accession":"0001144204-14-068371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-068371","line_url":"/filing/0001144204-14-068371#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.0599,"price_display":"5.06","price_state":"stated","total_value":505.99,"total_display":"505.99","shares_owned_after":881632.0,"shares_owned_after_display":"881,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-14","scope":"insider"},{"id":6747071,"accession":"0001144204-14-067698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-067698","line_url":"/filing/0001144204-14-067698#line-1","is_derivative":false,"issuer_cik":"0001535955","issuer_name":"Lipocine Inc.","issuer_ticker":"LPCN","issuer_name_source":null,"issuer_url":"/issuer/0001535955","owner_cik":"0001579872","owner_name":"Patel Mahesh V.","owner_url":"/insider/0001579872","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Cmmon Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.052,"price_display":"5.05","price_state":"stated","total_value":10104.0,"total_display":"10,104.00","shares_owned_after":879632.0,"shares_owned_after_display":"879,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-13","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001535955","name":"Lipocine Inc.","url":"/issuer/0001535955","role":"Director, Officer (Chief Executive Officer)","n_filings":22,"first_seen":"2014-11-13","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001579872","retrieved_at":"2026-08-21T10:26:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}